Amwill Healthcare’s IPO, involving a mix of fresh equity sale and OFS, has opened for investors with a price band of Rs 105-111 per share. The proceeds will fund various corporate activities. The share allotment is expected by February 10, with the listing slated for February 12.
Sun Pharma deal structurally strong, debt the only overhang: Amit Khurana
Market expert Amit Khurana offers insights on key corporate and regulatory developments. Sun Pharma’s acquisition is seen as strategically sound, though debt requires careful management.